HomeOTLK • NASDAQ
add
Outlook Therapeutics Inc
Previous close
$1.83
Day range
$1.79 - $1.95
Year range
$0.79 - $3.39
Market cap
116.69M USD
Avg Volume
5.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | -91.79K | — |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | -0.29 | 69.05% |
EBITDA | -17.28M | 24.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.08M | -45.85% |
Total assets | 18.58M | -35.52% |
Total liabilities | 50.77M | -50.17% |
Total equity | -32.19M | — |
Shares outstanding | 64.11M | — |
Price to book | -3.05 | — |
Return on assets | -211.28% | — |
Return on capital | 1,930.29% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | -12.38M | 27.12% |
Cash from investing | — | — |
Cash from financing | 11.56M | 10,155.73% |
Net change in cash | -817.73K | 95.22% |
Free cash flow | -7.87M | 14.48% |
About
Founded
2010
Website
Employees
17
